StockData
Solid Biosciences Inc. logo

Solid Biosciences Inc. (SLDB) stock

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.23−0.25 (-3.86%)

Close on Nov 17, 2026Market cap $668.01MP/E –Yield –

Solid Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

Solid Biosciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $167.40M, up 37.9% year over year. For fiscal 2025 it was $140.33M, up 45.5% from the year before. The highest annual figure on record is $140.33M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$140.33M+45.5%
FY2024Dec 31, 2024$96.43M+25.9%
FY2023Dec 31, 2023$76.56M-2.4%
FY2022Dec 31, 2022$78.42M+33.5%
FY2021Dec 31, 2021$58.74M-9.5%
FY2020Dec 31, 2020$64.88M-31.5%
FY2019Dec 31, 2019$94.74M+63.4%
FY2018Dec 31, 2018$57.97M+45.3%
FY2017Dec 31, 2017$39.91M+98.4%
FY2016Dec 31, 2016$20.12M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$44.27M+36.6%
Q1 FY2026Mar 31, 2026$46.14M+49.3%
Q4 FY2025Dec 31, 2025$38.14M+23.9%
Q3 FY2025Sep 30, 2025$38.86M+42.2%
Q2 FY2025Jun 30, 2025$32.42M+66.6%
Q1 FY2025Mar 31, 2025$30.91M+63.8%
Q4 FY2024Dec 31, 2024$30.77M+99.1%
Q3 FY2024Sep 30, 2024$27.33M+63.6%
Q2 FY2024Jun 30, 2024$19.46M-1.6%
Q1 FY2024Mar 31, 2024$18.87M-23.4%
Q4 FY2023Dec 31, 2023$15.45M-27.4%
Q3 FY2023Sep 30, 2023$16.70M+19.3%
Q2 FY2023Jun 30, 2023$19.78M-14.7%
Q1 FY2023Mar 31, 2023$24.63M+23.5%
Q4 FY2022Dec 31, 2022$21.29M+45.9%
Q3 FY2022Sep 30, 2022$14.01M-2.9%
Q2 FY2022Jun 30, 2022$23.18M+49.4%
Q1 FY2022Mar 31, 2022$19.95M+40.4%
Q4 FY2021Dec 31, 2021$14.60M-7.2%
Q3 FY2021Sep 30, 2021$14.43M-10.1%
Q2 FY2021Jun 30, 2021$15.51M+15.4%
Q1 FY2021Mar 31, 2021$14.21M-27.8%
Q4 FY2020Dec 31, 2020$15.72M-41.9%
Q3 FY2020Sep 30, 2020$16.05M-29.6%
Q2 FY2020Jun 30, 2020$13.45M-37.8%
Q1 FY2020Mar 31, 2020$19.67M-15.5%
Q4 FY2019Dec 31, 2019$27.07M+52.4%
Q3 FY2019Sep 30, 2019$22.79M+55.3%
Q2 FY2019Jun 30, 2019$21.61M+59.0%
Q1 FY2019Mar 31, 2019$23.27M+95.1%
Q4 FY2018Dec 31, 2018$17.76M+48.7%
Q3 FY2018Sep 30, 2018$14.68M+38.2%
Q2 FY2018Jun 30, 2018$13.59M+57.9%
Q1 FY2018Mar 31, 2018$11.93M+36.6%
Q4 FY2017Dec 31, 2017$11.95M–
Q3 FY2017Sep 30, 2017$10.62M–
Q2 FY2017Jun 30, 2017$8.61M–
Q1 FY2017Mar 31, 2017$8.73M–

More Solid Biosciences figures

See a number that looks wrong?